Mn Services Vermogensbeheer B.V. Cuts Stock Position in CME Group Inc. (NASDAQ:CME)

Mn Services Vermogensbeheer B.V. lessened its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 3.3% in the 3rd quarter, Holdings Channel reports. The firm owned 138,779 shares of the financial services provider’s stock after selling 4,700 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in CME Group were worth $30,622,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. QRG Capital Management Inc. lifted its holdings in shares of CME Group by 4.1% in the 3rd quarter. QRG Capital Management Inc. now owns 31,613 shares of the financial services provider’s stock valued at $6,975,000 after acquiring an additional 1,251 shares during the last quarter. Asset Management One Co. Ltd. increased its position in shares of CME Group by 0.8% during the third quarter. Asset Management One Co. Ltd. now owns 205,347 shares of the financial services provider’s stock worth $45,310,000 after acquiring an additional 1,700 shares during the period. National Pension Service increased its position in shares of CME Group by 9.0% during the third quarter. National Pension Service now owns 785,082 shares of the financial services provider’s stock worth $173,228,000 after acquiring an additional 64,499 shares during the period. Cohen Capital Management Inc. increased its position in shares of CME Group by 31.3% during the third quarter. Cohen Capital Management Inc. now owns 2,918 shares of the financial services provider’s stock worth $644,000 after acquiring an additional 696 shares during the period. Finally, Wetzel Investment Advisors Inc. increased its holdings in CME Group by 37.4% during the third quarter. Wetzel Investment Advisors Inc. now owns 2,342 shares of the financial services provider’s stock valued at $517,000 after buying an additional 638 shares during the period. Institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

NASDAQ CME traded down $0.77 during trading hours on Monday, hitting $222.84. 184,845 shares of the company’s stock traded hands, compared to its average volume of 1,909,385. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.36. The company has a market capitalization of $80.24 billion, a PE ratio of 23.51, a PEG ratio of 5.67 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The firm’s 50-day moving average is $220.69 and its 200-day moving average is $209.49.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. CME Group’s revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the business posted $2.25 EPS. Equities analysts forecast that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.06%. CME Group’s payout ratio is 48.37%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on CME shares. Oppenheimer lifted their price objective on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Piper Sandler boosted their target price on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Monday, October 28th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Finally, Bank of America boosted their target price on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus price target of $222.73.

Read Our Latest Analysis on CME Group

Insider Buying and Selling at CME Group

In other news, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the transaction, the insider now directly owns 7,275 shares in the company, valued at $1,652,298. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,221 shares of company stock worth $3,351,895 in the last ninety days. 0.30% of the stock is owned by insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.